Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Feature

May 6, 2014 — The National Lipid Association (NLA) recently convened an expert panel to examine various aspects of ...

Home May 06, 2014
Home
News

April 29, 2014 — Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a ...

Home April 29, 2014
Home
News

April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become ...

Home April 21, 2014
Home
Feature

April 10, 2014 — The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for ...

Home April 10, 2014
Home
News

April 9, 2014 — LipoScience Inc. announced data showing that patients managed to a target LDL particle (LDL-P) number ...

Home April 09, 2014
Home
Feature

April 7, 2014 — In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major ...

Home April 07, 2014
Home
Feature

April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular ...

Home April 07, 2014
Home
Feature

April 2, 2014 — Statins are associated with a significant improvement in erectile function, a fact researchers hope will ...

Home April 02, 2014
Home
News

March 25, 2014 – As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind ...

Home March 25, 2014
Home
News
March 25, 2014 — Patient enrollment has been completed four months ahead of plan in the Phase III clinical trial EUCLID ...
Home March 25, 2014
Home
News

March 18, 2014 — Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from ...

Home March 18, 2014
Home
News

March 12, 2014 — Janssen Research and Development LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) ...

Home March 12, 2014
Home
News

February 27, 2014 — Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk ...

Home February 27, 2014
Home
News
February 7, 2014 — Results from several late-breaking clinical trials will be presented during  the American College of ...
Home February 07, 2014
Home
News
February 3, 2014 — A large-scale analysis assessing the real-world risk of venous thromboembolism (VTE) in chemotherapy ...
Home February 03, 2014
Home
Subscribe Now